Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ratajczak, M. Z.
Right arrow Articles by Gewirtz, A. M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Ratajczak, M. Z.
Right arrow Articles by Gewirtz, A. M.

International Journal of Cell Cloning, Vol 10, 205-214, Copyright © 1992 by AlphaMed Press


REVIEWS

The c-kit proto-oncogene in normal and malignant human hematopoiesis

MZ Ratajczak, SM Luger and AM Gewirtz
Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia 19104.

The c-kit proto-oncogene encodes a tyrosine kinase receptor (KIT) which is expressed on many types of human cells. Numerous studies attest to the importance of the c-kit receptor and its ligand, known variously as stem cell factor (SCF), mast cell growth factor (MGF), Steel factor (SF), or kit ligand (KL) (the nomenclature we prefer), in the development of human hematopoietic cells. KL, which is produced in membrane-bound and soluble forms by bone marrow stromal cells, acts on pre-colony forming units (pre-CFU) and CFU cells. In synergistic combination with other cytokines, KL enhances the growth of myeloid progenitor cells. However, using an antisense oligodeoxynucleotide strategy to disrupt c-kit function, we have demonstrated that the KL- KIT complex is of greatest importance for generation and/or proliferation of normal human erythropoietic progenitor cells. In malignant hematopoietic cells, the complex also appears to be important for growth of granulocyte/macrophage (GM) CFU as well.


This article has been cited by other articles:


Home page
BloodHome page
N. Uchida, B. Dykstra, K. Lyons, F. Leung, M. Kristiansen, and C. Eaves
ABC transporter activities of murine hematopoietic stem cells vary according to their developmental and activation status
Blood, June 15, 2004; 103(12): 4487 - 4495.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Rudolph, U. Kellner, D. Schmidt, V. Kirchner, A. Talerman, D. Harms, and R. Parwaresch
Ki-A10, a Germ Cell Nuclear Antigen Retained in a Subset of Germ Cell-Derived Tumors
Am. J. Pathol., March 1, 1999; 154(3): 795 - 803.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 1992 by AlphaMed Press.